STOCK TITAN
  1. Home
  2. News
  3. MODD

Modular Medical Inc - MODD STOCK NEWS

Welcome to our dedicated news page for Modular Medical (Ticker: MODD), a resource for investors and traders seeking the latest updates and insights on Modular Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Modular Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Modular Medical's position in the market.

News
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
Rhea-AI Summary
Modular Medical, Inc. (NASDAQ:MODD) announces the appointment of Steve Gemmell as Vice President of Engineering. Gemmell brings over 20 years of experience in medical device product development and operations. He will lead the development of the MODD1+ insulin pump, aiming to make it user-friendly and affordable. The company plans to integrate the pump with various diabetes-related tools for better blood sugar management.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.02%
Tags
none
-
News
Registration Is Now Open for Tribe Public's Webinar Event "Revolutionizing Diabetes Care" Featuring Modular Medical CEO on Wednesday, March 6, 2024
Rhea-AI Summary
Modular Medical, Inc. (NASDAQ: MODD) is a development-stage company focused on creating user-friendly and affordable insulin pump technology. CEO Jeb Besser will present at a webinar on revolutionizing diabetes care. The company aims to empower the diabetes community with its innovative Insulin delivery device, MODD1.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.54%
Tags
none
-
News
Modular Medical Announces Closing of $10 Million Public Offering
Rhea-AI Summary
Modular Medical, Inc. (MODD) successfully closed an underwritten public offering of 9,090,910 shares of common stock, generating approximately $10 million in gross proceeds. The offering was led by Manchester Explorer, L.P. and other institutional investors at a price of $1.10 per share. The company intends to utilize the net proceeds for operational purposes, working capital, and general corporate needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.13%
Tags
offering
News
Modular Medical Announces Pricing of $10 Million Public Offering
Rhea-AI Summary
Modular Medical, Inc. (MODD) announces a public offering of 9,090,910 shares of common stock at $1.10 per share, led by Manchester Explorer, L.P., to raise approximately $10 million for insulin delivery technology development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
39.44%
Tags
offering
-
News
Modular Medical Announces Proposed Public Offering
Rhea-AI Summary
Modular Medical, Inc. (Nasdaq: MODD) has announced the commencement of an underwritten public offering of shares of its common stock or pre-funded warrants. The company also plans to grant the underwriter a 30-day option to purchase additional shares. The offering is subject to market conditions and Modular Medical will sell all the shares. Titan Partners Group is the sole book-running manager for the offering. The offering is made under an effective shelf registration statement and may only be offered through a prospectus.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
39.44%
Tags
offering
-
News
Modular Medical Announces Issuance of New US Patent
Rhea-AI Summary
Modular Medical, Inc. (NASDAQ:MODD) has announced the issuance of U.S. Patent 11,817,197 B2 for the stream-lined pairing of a pump to a mobile device. The patent protects the technology addressing pairing and the downloading of patient data, making it easier for clinicians to upload and review. The company's Chairman and CTO, Paul DiPerna, emphasized the importance of using technology to simplify the adoption and use of pump technology for patients and caregivers, addressing cybersecurity risks and the complexity of pairing multiple devices. The CEO, Jeb Besser, highlighted the strategic value of their patents and the company's positioning in the market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
none
News
Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump
Rhea-AI Summary
Modular Medical, Inc. (MODD) has announced the premarket submission of its MODD1 next-generation insulin pump to the FDA for 510(k) clearance. The company aims to launch a user-friendly and affordable insulin pump technology to change the diabetes market. The CEO and Chairman believe that the simplified design will encourage more people to adopt technology for diabetes management. The company also plans to obtain the UKCA mark to market the MODD1 in the United Kingdom and move its pilot production line to prepare for commercial launch.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.92%
Tags
none
-
News
Modular Medical Announces Collaboration with Glooko
Rhea-AI Summary
Modular Medical, Inc. (Nasdaq:MODD) announced a collaboration agreement with Glooko, Inc. to integrate Glooko's platform with Modular Medical's insulin pump technology. This collaboration aims to provide clinicians and patients with user-friendly access to insulin dosing data and glucose levels, aligning with Modular Medical's vision of affordable and accessible diabetes care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
none
-
News
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes Care For The Rest Of Us." Featuring Modular Medical CEO On Friday, December 15, 2023
Rhea-AI Summary
Modular Medical, Inc. (Nasdaq: MODD) is a development-stage insulin delivery technology company aiming to launch a user-friendly and affordable insulin pump technology. CEO Jeb Besser will present at Tribe Public's Webinar Presentation and Q&A Event titled 'Diabetes Care For The Rest Of Us' on December 15, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.75%
Tags
none
News
Modular Medical to Attend the Benchmark Company's Upcoming Discovery One-on-One Investor Conference
Rhea-AI Summary
Modular Medical, Inc. (Nasdaq:MODD) announced its participation in the Benchmark Company's 12th Annual Discovery One-on-One Investor Conference. The event, to be held on December 7, 2023, will provide the company's CEO, Jeb Besser, the opportunity to engage with analysts and investors. The conference aims to offer emerging growth and dynamic publicly traded companies access to institutional and individual investors in a unique one-on-one format.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
conferences
Stock MODD logo
Modular Medical Inc

Nasdaq:MODD

MODD Rankings

#4756 Ranked by Market Cap
#5027 Ranked by Stock Gains
N/A Ranked by Dividends

MODD Stock Data

48.65M
16.10M
10.35%
25.99%
0.74%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
San Diego

About MODD

modular medical ltd is a company based out of beacon house orchard farm ivinghoe aston, buckinghamshire, united kingdom.